Newsletter of COMPAMED | View in browser | Deutsch | Print
Photo: Header picture of COMPAMED Newsletter

Mini factories from the 3D printer

Dear Sir or Madam,

Wound healing from the 3D printer? In the future, it will be possible to create all possible shapes and functionalities with 3D printing. Researchers have now succeeded in printing a material that contains bacteria and thus continuously produces new ones. These "mini-factories" could contribute to the healing of burn injuries or to environmental protection. Read more in our News.

A great week wishes

Julia Unverzagt
Editorial team COMPAMED-tradefair.com
Image: 12 - 15 November 2018, COMPAMED - HIGH-TECH SOLUTIONS FOR MEDICAL TECHNOLOGY

Content

Special: 3D Printing
Newsletter Service
Newsletter Archive
RSS Service

3D Printing in regenerative medicine: a custom-made treatment?

Image: Two skull models with 3D printed implants; Copyright: beta-web
Generative manufacturing processes such as 3D printing have been inspiring both the technology industry and medical technology for years. 3D printing is particularly interesting for the production of individual patient implants. In this context, the focus is increasingly on more than just massive implants such as endoprostheses or dentures. Research is increasingly looking at printed implants that are absorbed by the body while new tissue is being created in their place. Find out what role 3D printing and bioprinting play in this process in our current Special.
Click here for the article!
3D Printing in regenerative medicine: a custom-made treatment?
Read more of our Special November
To top

Innovations

MRI scans predict patients' ability to fight the spread of cancer

A simple, non-invasive procedure that can indicate how long patients with cancer that has spread to the brain might survive and whether they are likely to respond to immunotherapy has been developed by researchers in Liverpool.
read more
To top

Innovations

Scientists discover possible master switch for programming cancer immunotherapy

Researchers report the discovery that a protein called "Runx3" programs killer T cells to establish residence in tumors and infection sites.
read more
To top

Innovations

3D-printed minifactories

There will soon be nothing that cannot be produced with 3D printing. However, the materials used for this process are still "dead matter" such as plastics or metals.
read more
To top

Innovations

Scientist at Kiel University receive EU funding to develop new implantats

During a heart attack muscle tissue can be damaged or can even die when cells are not provided with enough oxygen. A research team from Kiel University (CAU) has developed a biomaterial to regenerate and restore harmed tissue and lead to faster treatment. The scientists made use of the fact that cells react to stimuli from their environment.
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.COMPAMED.de/news_abo_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@compamed.de.
To top

beta-web GmbH - Partner of Messe Düsseldorf

Advertising opportunities

As an official partner of Messe Düsseldorf, beta-web markets exclusive forms of advertisements to exhibitors of the COMPAMED.

You want to be part of the newsletter and reach over 13.000 interested readers with your advertising message? Then contact us at compamed@beta-web.de or call us: 0049 – 228 9193735.

For more information on our available forms of advertisements, please see our Media Kit.
Click here for the website of beta-web GmbH
beta-web GmbH
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.